Picture a world where most life-saving medicines are discovered not in the United States, but in Beijing and Shanghai. Imagine a time when the most advanced biotechnologies, therapies that cure ...

CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) net trade sales of approximately $524 millionEC and U.S. FDA label updates for CARVYKTI® to ...

This week is turning out to be a strong one for those anticipating clearer crypto regulations. On Nov. 10, the Senate ...

Wondering if Barrick Mining is really a bargain right now? You are not alone. With the gold sector heating up, this is the perfect time to dig into the numbers. The stock has delivered an eye-catching ...

CompletedstrategicpivotfromR&Dfocustocommercial focusRebranded as Dyadic Applied BioSolutions and launched redesigned website to optimize ...

Agriculture and natural resources major Daisy Creel immerses herself in animal and food science, agribusiness and policy ...

Armata Pharmaceuticals, Inc. ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the ...

Innoviz Technologies Ltd.  (the "Company" or "Innoviz"), a leading Tier-1 direct supplier of high performance, automotive-grade LiDAR sensor platforms and complementary software stack, today provided ...

CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) net trade sales of approximately $524 millionEC and U.S. FDA label updates for CARVYKTI® to include overall survival benefit versus standard of care Ov ...

Silexion continues to advance operational readiness for its planned Phase 2/3 clinical trials of SIL204, with toxicology ...

PUMA has relaunched its online magazine CATch UP with a bold new design and editorial focus, showcasing the company’s innovations, corporate culture, and strategic vision as it embarks on a ...